Cargando…

Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications

BACKGROUND: Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better understand the burden (both from an epidemiological and economic perspective) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamri, Larbi, Gripiotis, Erofile, Ferrario, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943499/
https://www.ncbi.nlm.nih.gov/pubmed/24564974
http://dx.doi.org/10.1186/1744-8603-10-11
_version_ 1782306276982652928
author Lamri, Larbi
Gripiotis, Erofile
Ferrario, Alessandra
author_facet Lamri, Larbi
Gripiotis, Erofile
Ferrario, Alessandra
author_sort Lamri, Larbi
collection PubMed
description BACKGROUND: Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better understand the burden (both from an epidemiological and economic perspective) and management of diabetes. The second objective is to understand the health policy strategy adopted by Algeria in order to respond to the disease. METHODS: We conducted a literature review of prevalence, costs, management and outcomes of diabetes and its complications. This was complemented by data compilations and results of expert consultations. RESULTS: The epidemiology of diabetes is continually evolving and is becoming more problematic. The national evidence suggests that the prevalence of diabetes in Algeria has increased from 6.8% in 1990 to 12.29% in 2005, but is quite higher among certain groups and areas of the country. This disease affects all population groups, especially 35–70 year olds, who constitute a large segment of the working population. There are very few estimates of the cost of diabetes. These include a 1998 study on the total cost of type 1 diabetes (USD 11.6 million, which, inflated to 2013 value, totals to USD 16.6 million), a study on the cost of complications in 2010 (at 2013 value, ranging from USD 141 for first-year treatment of peripheral vascular disease to USD 30,441 for first-year cost of renal transplantation) and the 2013 IDF estimates of total cost of type 1 and type 2 diabetes (USD 513 million). CONCLUSIONS: As the prevalence of diabetes continues to increase, the financial burden will increasingly weigh heavily on social security resources and the government budget. Future priorities must focus on empowering general practitioners in treating type 2 diabetes, improving screening of diabetes and its complications, tackling the growing obesity epidemic, strengthening health information systems and implementing the national diabetes prevention and control plan.
format Online
Article
Text
id pubmed-3943499
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39434992014-03-06 Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications Lamri, Larbi Gripiotis, Erofile Ferrario, Alessandra Global Health Research BACKGROUND: Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better understand the burden (both from an epidemiological and economic perspective) and management of diabetes. The second objective is to understand the health policy strategy adopted by Algeria in order to respond to the disease. METHODS: We conducted a literature review of prevalence, costs, management and outcomes of diabetes and its complications. This was complemented by data compilations and results of expert consultations. RESULTS: The epidemiology of diabetes is continually evolving and is becoming more problematic. The national evidence suggests that the prevalence of diabetes in Algeria has increased from 6.8% in 1990 to 12.29% in 2005, but is quite higher among certain groups and areas of the country. This disease affects all population groups, especially 35–70 year olds, who constitute a large segment of the working population. There are very few estimates of the cost of diabetes. These include a 1998 study on the total cost of type 1 diabetes (USD 11.6 million, which, inflated to 2013 value, totals to USD 16.6 million), a study on the cost of complications in 2010 (at 2013 value, ranging from USD 141 for first-year treatment of peripheral vascular disease to USD 30,441 for first-year cost of renal transplantation) and the 2013 IDF estimates of total cost of type 1 and type 2 diabetes (USD 513 million). CONCLUSIONS: As the prevalence of diabetes continues to increase, the financial burden will increasingly weigh heavily on social security resources and the government budget. Future priorities must focus on empowering general practitioners in treating type 2 diabetes, improving screening of diabetes and its complications, tackling the growing obesity epidemic, strengthening health information systems and implementing the national diabetes prevention and control plan. BioMed Central 2014-02-24 /pmc/articles/PMC3943499/ /pubmed/24564974 http://dx.doi.org/10.1186/1744-8603-10-11 Text en Copyright © 2014 Lamri et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Lamri, Larbi
Gripiotis, Erofile
Ferrario, Alessandra
Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title_full Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title_fullStr Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title_full_unstemmed Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title_short Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
title_sort diabetes in algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943499/
https://www.ncbi.nlm.nih.gov/pubmed/24564974
http://dx.doi.org/10.1186/1744-8603-10-11
work_keys_str_mv AT lamrilarbi diabetesinalgeriaandchallengesforhealthpolicyaliteraturereviewofprevalencecostmanagementandoutcomesofdiabetesanditscomplications
AT gripiotiserofile diabetesinalgeriaandchallengesforhealthpolicyaliteraturereviewofprevalencecostmanagementandoutcomesofdiabetesanditscomplications
AT ferrarioalessandra diabetesinalgeriaandchallengesforhealthpolicyaliteraturereviewofprevalencecostmanagementandoutcomesofdiabetesanditscomplications